ImmunizeDelaware

ImmunizeDelaware The ICD is a diverse group of partners working together to ensure that no one in Delaware suffers from vaccine preventable illnesses.

The Immunization Coalition of Delaware, a program of the Delaware Academy of Medicine / Delaware Public Health Association, is a diverse group of partners working together to ensure that no one in Delaware suffers from vaccine preventable illnesses.

Happy Rainy Wednesday, Delaware! Need some reading material?
04/22/2026

Happy Rainy Wednesday, Delaware! Need some reading material?

Keep updated on immunization news. Read IZ Express Issue Number 1870.

04/22/2026

RSV hits hard at both ends of the age spectrum. Globally, it causes 33 million infections and over 100,000 deaths in kids under 5 every year, and it’s the leading cause of lower respiratory tract infections in young children. And severe cases aren’t limited to preemies or kids with underlying conditions. A recent Swedish study found the median age of infants admitted to the ICU for RSV was under 2 months. For older adults hospitalized with RSV, about 1 in 10 end up in the ICU, and roughly 12% die within 30 days. Because there’s no antiviral, all we can offer once someone is sick is supportive care. That’s what makes the preventatives we have SO IMPORTANT, whether that’s maternal vaccination during pregnancy, a monoclonal antibody for infants, or vaccination for older adults.

https://www.cidrap.umn.edu/influenza-general/rsv-tied-high-complication-death-rates-hospitalized-older-adults
https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/rsv-symptoms-older-adults-often-linger-studies-show
https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/severe-rsv-doesnt-spare-healthy-full-term-infants-data-suggest

This is a good one!
04/20/2026

This is a good one!

My daughter is an animal lover in the truest sense. Our house is essentially a zoo of stuffed creatures—capybaras, axolotls, highland cows, you name it. When she discovered Squishmallows, my wallet felt it immediately. I gently pushed back and encouraged her to reconsider, and my gracious girl too...

Happy Monday, Delaware! Hope you had a great weekend! https://immunizedelaware.org/wp-content/uploads/April-20.pdf
04/20/2026

Happy Monday, Delaware! Hope you had a great weekend!https://immunizedelaware.org/wp-content/uploads/April-20.pdf

04/17/2026

Tylenol during pregnancy has no link to autism, large study finds

It's Wednesday! Have an IZ Express, on us!
04/15/2026

It's Wednesday! Have an IZ Express, on us!

Keep updated on immunization news. Read IZ Express Issue Number 1869.

04/13/2026
04/13/2026

A completed CDC report showing the COVID vaccine reduced ER visits and hospitalizations in healthy adults by about HALF last winter was just blocked from publication by the acting CDC director. It had cleared internal scientific review and was scheduled for March 19 in the MMWR (the CDC’s primary vehicle for publishing public health data and findings). The stated reason was concerns about the methodology. So let’s talk about it…

The methodology in question is called test-negative design, and there’s a very good reason why it became the standard for measuring vaccine effectiveness over the past two decades.

Randomized controlled trials sound more rigorous on paper, but for an already-recommended vaccine they’re both logistically impractical and ethically complicated — you can’t easily ask people to accept a placebo for something they’re already advised to get.

Test-negative design works differently: you look at people already sick enough to seek care, test them, and compare vaccination rates between those who test positive and those who don’t. Starting at the point of care controls for a major confounding problem (because people who seek medical attention are systematically different from those who don’t). Like all study designs, it has limitations — it only captures people seeking care, not the broader population, and selection bias can enter if testing isn’t applied consistently. Researchers know this, account for it in their analyses, and use it to inform how findings are interpreted.

The flu vaccine effectiveness report published in the same MMWR one week earlier used this exact method. No concerns were raised. Why the double standard? 🤔

This leads us to believe that the demand for a different methodology isn’t coming from a place of genuine scientific concern; we stopped doing placebo-controlled trials for recommended vaccines largely for ethical reasons. You don’t withhold a recommended intervention from half your study population to satisfy a methodological preference. That’s NOT a higher standard. The people raising these objections know that, or at least they should.

Happy Monday! Have a Week in Review! https://immunizedelaware.org/wp-content/uploads/April-13.pdf
04/13/2026

Happy Monday! Have a Week in Review!https://immunizedelaware.org/wp-content/uploads/April-13.pdf

Happy Wednesday!
04/08/2026

Happy Wednesday!

Keep updated on immunization news. Read IZ Express Issue Number 1868.

04/06/2026
Happy Monday, y'all! Hope everyone had a nice weekend! https://immunizedelaware.org/wp-content/uploads/April-6.pdf
04/06/2026

Happy Monday, y'all! Hope everyone had a nice weekend!

https://immunizedelaware.org/wp-content/uploads/April-6.pdf

Address

Suite L10, 4765 Ogletown-Stanton Road
Newark, DE
19713

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when ImmunizeDelaware posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share